DSEN Organizational chart

DSEN’s research teams and Collaborating Centres now form a coordinated national network of over 200 researchers committed to the highest excellence in post-market drug safety and effectiveness research. This coordinated national network creates the capacity to respond in a timely manner to the drug safety and effectiveness queries of decision makers.

Drug Safety and Effectiveness Network

Organizational Chart (February 2019)

Organizational Chart – Long Description

The Drug Safety and Effectiveness Network (DSEN) is organized under the Canadian Institutes of Health Research with its DSEN Coordinating Office (DSEN CO). The DSEN CO links horizontally to three advisory bodies: to the DSEN Steering Committee and the Science Advisory Committee on the right, and to the DSEN Executive Working Group on the left.

Under the DSEN CO there are three Collaborative Centres based on methodologies. These collaborative centres focus on Observational Studies, Prospective Studies, and Network Meta-Analysis and are formed by four DSEN funded Research Teams.

The Collaborative Centre for Observational Studies is composed of the Canadian Network for Observational Drug Effect Studies (CNODES – 95 researchers). The DSEN Active Surveillance and Evaluation of Adverse reactions in Canadian Healthcare & the Pharmaco-genomics of Adverse Events National Team (SEARCH & PREVENT – 31 researchers), and the Canadian Network for Advanced Interdisciplinary Methods for Comparative Effectiveness Research (CAN-AIM – 61 researchers), cumulatively form the Collaborating Centre for Prospective Studies. The Collaborating Centre for Network Meta-Analysis is comprised of one team: the Methods and Applications Group for Indirect Comparisons (MAGIC) (50 researchers).

Date modified: